Vaccines

7 June 2016

VAXIMM Presents Data from Phase I Trial in Pancreatic Cancer with Oral T-cell Immunotherapy VXM01 at ASCO 2016 Annual Meeting

5 June 2016

OBI Pharma Presents Data For Novel Investigational OBI-822/OBI-821 In Patients With Metastatic Breast Cancer At The 2016 American Society Of Clinical Oncology Annual Meeting

2 June 2016

Valneva´s Pseudomonas Aeruginosa Candidate (VLA43) Did Not Confirm Positive Vaccine Effect in Phase II/III trial

2 June 2016

Targovax receives approval in Australia to conduct a clinical trial with TG02 – an immunotheraphy treatment targeting RAS mutations

25 May 2016

ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease

24 May 2016

Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four years of age and older

24 May 2016

Bavarian Nordic Announces Positive Top Line Results from a Phase 1 Trial of a Novel, Broad Spectrum RSV Vaccine in Healthy Adult and Elderly Populations

21 May 2016

Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine)

16 May 2016

This Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses in Non-Human Primates

14 May 2016

Pfizer Presents Results from Two Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Studies at the European Society for Paediatric Infectious Diseases Meeting

14 May 2016

NeOnc Technologies Announces Initiation of Phase 1/2a Clinical Trial of NEO100™ in Recurrent Glioblastoma Multiforme (GBM)

12 May 2016

OncBioMune Provides Update on Phase 2 Clinical Trials of ProscaVax for Prostate Cancer

11 May 2016

NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel-L for Patients with Resected Pancreatic Cancer

10 May 2016

Dr. Patrick Soon-Shiong Presents Promising Results of Novel Adenoviral Colon Cancer Vaccine in Treating End-Stage Colon Cancer at the Bank of America Merrill Lynch 2016 Health Care Conference

9 May 2016

Allergy Therapeutics announces positive top-line results from the PQBirch204 Phase II study for birch-induced seasonal allergic rhinitis

4 May 2016

SELLAS Life Sciences Announces Positive WT1 Cancer Vaccine (galinpepimut-S) Clinical Results at the 13th International Conference of the International Mesothelioma Interest Group (iMig)

4 May 2016

VAXIMM initiates Phase 2a study in advanced colorectal cancer with oral T-cell vaccine VXM01

2 May 2016

Pharos Biologicals Conducting Tests of a Novel Zika Vaccine

2 May 2016

SELLAS Life Sciences Group Announces Initiation of Galinpepimut-S (WT1 Cancer Vaccine) Phase 1 Clinical Trial in Combination with PD-1 Checkpoint Inhibitor for Patients with Ovarian Cancer

29 April 2016

CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders

26 April 2016

Journal of the American Medical Association Publishes Phase III Data from Allergic Asthma Trial with ALK’s House Dust Mite SLIT-tablet, ACARIZAX

21 April 2016

TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute

19 April 2016

Global Public-Private Partnership Announces Publication of Positive Phase 1 Data for Ebola Vaccine Regimen in JAMA

19 April 2016

Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data at the American Association for Cancer Research (AACR) Annual Meeting

13 April 2016

PDS Biotechnology Reports Positive Phase 1 Study Results for PDS0101 Immunotherapy for HPV-Related Cancers

13 April 2016

Merck Announces FDA Acceptance of Biologics License Application for Investigational House Dust Mite Sublingual Allergy Immunotherapy Tablet

12 April 2016

DBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy

11 April 2016

Aimmune Therapeutics Presents Data on Biomarkers and Potential to Predict Response to Peanut Allergy Treatment With AR101

5 April 2016

Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate

2 April 2016

Pandemic influenza vaccine receives positive CHMP opinion

News Channels

Newsletter

La Merie Biologics

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.

Newsletter La Merie Biologics

Newsletter

New Product Alert

La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.

Newsletter new product alert

Featured reports

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

GPC3-Targeted Immunotherapy Pipeline Review

Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective

B7-H4 Targeted Antibody Therapy Pipeline Review

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Adalimumab (Humira) Biosimilars Pipeline Review

Report Package: Claudin 18.2-Targeted Immunotherapeutics

Report Package: Bispecific Antibodies

5T4-Targeted Immunotherapy Candidates Pipeline Review